Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1997-11-13
1999-10-26
Stucker, Jeffrey
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4242081, 514 2, 530324, 530325, 530326, 530327, 530328, 530350, A01N 6500
Patent
active
059723394
ABSTRACT:
A method of producing an HIV-specific helper T cell response in an animal by (1) providing a polypeptide 8 to 50 amino acid residues in length and having a helper T cell epitope of a HIV-1 p24 peptide; and (2) administering to the animal an amount of the polypeptide sufficient to produce an HIV-specific helper T cell response.
REFERENCES:
patent: 4943628 (1990-07-01), Rosen et al.
patent: 5639854 (1997-06-01), Sia et al.
Autran et al., "Positive Effects of Combined Antiretroviral Therapy in CD4+T Cell Homeostasis and Function in Advanced HIV Disease", Science 277:112-116, 1997.
Battegay et al., "Enhanced Establishment of a Virus Carrier State in Adult CD4+ T Cell-Deficient Mice", Journal of Virology 68:4700-4704, 1994.
Berzofsky et al., "Antigenic Peptides Recognized by T Lymphocytes from AIDS Viral Envelop-immune Humans", Nature 334:706-708, 1988.
Connors et al., "HIV Infection Induces Changes in CD4+ T-Cell Phenotype and Depletions Within the CD4+ T-Cell Repertoire that are not Immediately Restored . . .", Nature Medicine 3:533-540, 1997.
Johnson et al., "HIV-1 gag-Specific Cytotoxic T Lymphocytes Recognize Multiple Highly Conserved Eptiopes", The Journal of Immunology 147:1512-1521, 1991.
Kelleher et al., "Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, . . ."The Journal Infectious Diseases 173:321-329, 1996.
Lekutis et al., "HIV-1 env DNA Vaccine Administered to Rhesus Monkeys Elicits MHC Class II-Restricted CD4+ T Helper Cells That Secrete . . .", The Journal of Immunology pp. 4472-4477, 1977.
Matloubian et al., "CD4+ T Cells Are Required to Sustain CD8+ Cytotoxic T-Cell Responses During Chronic Viral Infection", Journal of Virology 68:8056-8063, 1994.
Planz et al., "A Critical Role for Neutralizing-antibody-producing B Cells, CD4+ T Cells, and Interferons in Persistent and Acute Infections of Mice . . . ", Proc. Natl. Acad. Sci. 94:6874-6879, 1997.
Schnittman et al., "Preliminary Evidence for Partial Restoration of Immune Function in HIV Type 1 Infection with Potent Antiretroviral Therapies: . . .", AIDS Research and Human Retroviruses 13:815-818, 1997.
Schrier et al., "T Cell Recongnition of HIV Synthetic Peptides in a Natural Infection", The Journal of Immunology 142:1166-1176, 1989.
Shearer et al., "Method for Detecting Immune Dysfunction in Asymptomatic AIDS (Acquired Immunodeficiency Syndrome) Patients and Other Conditions", U.S. Dept. of Commerce NTIS PB89-189997, 1989.
Thomsen et al., "Exhaustion of CTL Memory and Recrudescence of Viremia in Lymphocytic Choriomeningitis Virus-Infected MHC Class II-Deficient Mice . . .", The Journal of Immunology pp. 3074-3080, 1996.
Von Herrath et al., "CD4-Deficient Mice Have Reduced Levels of Memory Cytotoxic T Lymphocytes after Immunization and Show Diminished . . . ", Journal of Virology 70: 1072-1079, 1996.
Wahren et al., "Characteristics of Specific Cell-Mediated Immune Response in Human Immunodeficiency Virus Infection", Journal of Virology 61:2017-2023, 1987.
Walter et al., "Reconstitution of Cellular Immunity Against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones From the Donor", The New England Journal of Medicine 333:1038-1044, 1995.
Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, edited by James Bennington, W.B. Saunders Co., Philadelphia, p. 30, 1984.
Harding et al. Cell, vol. 64(1991), pp. 393-401.
Stucker Jeffrey
The General Hospital Corporation
LandOfFree
Method of eliciting anti-HIV-1 helper T cell responses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of eliciting anti-HIV-1 helper T cell responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of eliciting anti-HIV-1 helper T cell responses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-760698